Cipla - Latest News on Cipla | Read Breaking News on Zee News

Global cues to dictate trend at the domestic bourses: Experts

Last Updated: Sunday, March 16, 2014, 12:44

Stock markets will remain shut on Monday for 'Holi'.

Sensex tumbles 255 pts to four-month low; Cipla, Coal India tank

Last Updated: Thursday, February 13, 2014, 16:08

The benchmark Sensex Thursday plunged 255 points to a four-month closing low of 20,193.35 on poor earnings of Cipla and Coal India, weak global cues and continued worries over the domestic economy.

Cipla shares tank over 6% as Q3 earnings lag estimates

Last Updated: Thursday, February 13, 2014, 12:37

At the NSE, Cipla's scrip tanked 6.17 percent to Rs 387.25.

Cipla acquires Croatia-based Celeris

Last Updated: Thursday, December 05, 2013, 16:03

Drug major Cipla on Thursday said its wholly owned subsidiary has acquired Croatia based firm Celeris d.O.O, distributor of its products in that country.

Cipla ups stake in Ugandan firm, acquires 14.5% for $15 million

Last Updated: Thursday, November 21, 2013, 15:17

Pharma firm Cipla Ltd on Thursday said it has gained majority stake in Uganda-based Quality Chemical Industries Ltd with the acquisition of additional 14.5 per cent stake for USD 15 million.

Cipla chief calls for ‘obligatory’ drugs licenses

Last Updated: Friday, August 16, 2013, 21:44

The chairman of India’s oldest pharmaceutical firm Cipla has asked the Indian government to push for "obligatory licensing" of drugs to improve access to essential medicines in the Third World.

Morgan Stanley downgrades Cipla to "underweight"

Last Updated: Tuesday, August 13, 2013, 14:57

Morgan Stanley downgraded Cipla Ltd to "underweight" from "equal-weight" and reduces its target price on the stock to Rs 386 from Rs 414 citing slower growth prospects and valuations.

Cipla Q1 net up 10% at Rs 485 crore

Last Updated: Friday, August 09, 2013, 19:24

The company had posted a net profit of Rs 440.10 crore in the April-June quarter of 2012-13 fiscal.

Cipla spends Rs 274 cr to set up API facilities

Last Updated: Sunday, August 04, 2013, 17:45

Pharma major Cipla has spent Rs 274 crore towards setting up an Active Pharmaceutical Ingredient (API) R&D facility at Patalganga in Maharashtra, and commenced commercial production of anticancer APIs at Bommasandra, Bengalore and anti-ulcerant APIs at Kurkumbh in Maharashtra.

Drugs pricing row: HC extends relief to Cipla Ltd till Aug 27

Last Updated: Tuesday, July 30, 2013, 19:22

Delhi High Court on Tuesday extended the operation of its earlier order asking the Centre not to take coercive steps against pharma major Cipla Ltd which was told to replace stocks in the market with those carrying reduced prices within 45 days of new price notification.

HC asks Centre not to take coercive steps against Cipla

Last Updated: Friday, July 26, 2013, 20:35

The court, meanwhile, asked the firm to supply the revised price list of regulated medicines to its distributors, suppliers and retailers.

Cipla completes buyout of Cipla Medpro for Rs 2,707 cr

Last Updated: Tuesday, July 16, 2013, 15:45

Drug major Cipla on Tuesday said it has completed the buyout process of South African pharma firm Cipla Medpro for an aggregate consideration of Rs 2,707 crore.